Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/2007

01-04-2007 | Original Paper

A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approaches

Authors: Janet E. Olson, James N. Ingle, Cynthia X. Ma, Linda L. Pelleymounter, Daniel J. Schaid, V. Shane Pankratz, Robert A. Vierkant, Zachary S. Fredericksen, Yanhong Wu, Fergus J. Couch, Celine M. Vachon, Thomas A. Sellers, Richard M. Weinshilboum

Published in: Breast Cancer Research and Treatment | Issue 2/2007

Login to get access
Metadata
Title
A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approaches
Authors
Janet E. Olson
James N. Ingle
Cynthia X. Ma
Linda L. Pelleymounter
Daniel J. Schaid
V. Shane Pankratz
Robert A. Vierkant
Zachary S. Fredericksen
Yanhong Wu
Fergus J. Couch
Celine M. Vachon
Thomas A. Sellers
Richard M. Weinshilboum
Publication date
01-04-2007
Published in
Breast Cancer Research and Treatment / Issue 2/2007
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-006-9324-7

Other articles of this Issue 2/2007

Breast Cancer Research and Treatment 2/2007 Go to the issue

Epidemiology

Cost-effectiveness of different reading and referral strategies in mammography screening in the Netherlands

Erratum

A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women

Original paper

Effect of undertreatment on the disparity in age-related breast cancer-specific survival among older women

Epidemiology

BRCA1 and BRCA2 status in a Central Sudanese series of breast cancer patients: interactions with genetic, ethnic and reproductive factors

Preclinical Study

Gene expression profiling of breast cancer cells in response to gemcitabine: NF-κB pathway activation as a potential mechanism of resistance

Clinical Trial

Risk factors for breast cancer in older women: the relative contribution of bone mineral density and other established risk factors
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits